DrugPipeline.net has announced the addition of “Australia Market Report for Central Venous Catheters 2017 - MedCore” research report to their website DrugPipeline.net
Bangalore, Karnataka -- (SBWIRE) -- 02/08/2017 -- General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The total CVC market includes both acute and chronic CVCs. Overall market decreases are due to declines in both the sale of chronic CVC and acute CVC market. Competing devices, mainly PICCs, have substantially eroded growth in sales of CVCs. Unit sales have been on a slow but steady decline in Australia for the last several years; these increases are expected to continue over the forecast period as the adoption for competing products such as PICCs continue to grow exponentially across the globe. As unit sales growth slows, companies are decreasing their prices in order to maintain market share, this increases the rate at which the market is declining. Additionally, CVCs are perceived to have a higher infection rate than other long-dwelling catheters such as PICCs and many manufacturers offer antimicrobial or antibacterial CVCs to try to counteract this higher infection risk. However, these devices have been available for a long period of time. Their usage is not expected to increase significantly.
In 2016, the market for acute CVCs in Australia decreased over the previous year. This market value included acute and chronic CVC catheters. However, chronic CVC catheters comprise less than 9% of total CVC unit sales; their contribution to the overall market value is insignificant and is quickly falling out of favour in most established markets. The use of CVCs for parenteral nutrition is being pressured by intraoral feeding and the use of PICCs. Therefore, CVCs unit sales are expected to decline despite the rise in the number of seriously ill patients and more complex treatment regimens that require the use of CVCs. Despite the fact that PICCs are associated with lower infections, the use of PICCs has grown significantly at the expense of CVCs in Australia, whereas practitioners in Japan prefer to use CVCs.
Spanning over 441 pages "Australia Market Report for Central Venous Catheters 2017 - MedCore" report covers Executive Summary, Australia Vascular Access Device and Accessories Market Overview, Competitive Analysis, Market Trends, Research Methodology, Disease Overview, Product Assessment, Central Venous Catheter Market, Appendix. The Report Covered Companies are - C. R. Bard, Becton Dickinson, Teleflex, Smiths Medical, B. Braun, Cook Medical, Medcomp, Angiodynamics, Medtronic, Baxter
For more information Visit at: http://www.drugpipeline.net/idata-research/australia-market-report-central-venous-catheters-2017-medcore
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.